Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
62.4% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
6
users have commented on this narrative
49
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
30.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
28
users have liked this narrative
5
users have commented on this narrative
77
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
19.2% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
10
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Xiaomi
AN
AnalystLowTarget
Consensus Narrative from 32 Analysts
Rising Geopolitical And Regulatory Hurdles Will Squeeze Margins
Key Takeaways Rising regulatory barriers, supply chain instability, and data privacy concerns pose significant risks to international expansion and market diversification efforts. Margin pressures from product commoditization, rapid industry changes, and overexpansion threaten profitability and long-term financial sustainability.
View narrative
HK$45.38
FV
19.0% overvalued
intrinsic discount
15.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
14 days ago
author updated this narrative
GSK
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
US Inflation Reduction Act And Patent Cliffs Will Erode Margins
Key Takeaways Global pricing pressures, regulatory reforms, and litigation risks are expected to compress GSK's profitability and raise compliance costs. Heavy reliance on a few blockbuster products exposes GSK to significant competition, patent expiries, and market share erosion.
View narrative
UK£11.20
FV
22.6% overvalued
intrinsic discount
2.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
14 days ago
author updated this narrative
SK hynix
AN
AnalystLowTarget
Consensus Narrative from 36 Analysts
Semiconductor Margins Will Suffer Amid Deglobalization And Regulation
Key Takeaways Intensifying trade barriers and environmental regulations are set to drive up SK hynix's costs and strain access to crucial export markets. Advances in quantum computing and new competitors threaten SK hynix's traditional memory business, leading to persistent pricing pressures and volatile profitability.
View narrative
₩205.16k
FV
26.0% overvalued
intrinsic discount
5.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
14 days ago
author updated this narrative
British American Tobacco
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Strict Regulations In Australia And Bangladesh Will Sap Long-Term Potential
Key Takeaways Ongoing global regulatory tightening and the rise of illicit trade are eroding BAT's legal sales, compressing margins, and diminishing pricing power. Declining cigarette demand and ESG-driven divestment challenge BAT's revenue base, with alternative products and litigation risks further weighing on profitability and returns.
View narrative
UK£26.50
FV
59.7% overvalued
intrinsic discount
0.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
14 days ago
author updated this narrative
Chugai Pharmaceutical
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Pricing Pressures And Concentration Risks Will Erode Future Valuations
Key Takeaways Heavy dependence on select products, the Roche alliance, and volatile export factors creates significant risks to revenue stability and future earnings. Increasing regulatory, pricing, and operational pressures threaten margins, R&D success, and overall long-term profitability.
View narrative
JP¥6.10k
FV
21.5% overvalued
intrinsic discount
0.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
14 days ago
author updated this narrative
EssilorLuxottica Société anonyme
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Shrinking Demographics And E-Commerce Will Undermine Eyewear Value
Key Takeaways Market dynamics like shrinking demand, income inequality, and disruptive technologies threaten revenue growth, volume opportunities, and long-term profitability. Increased competition from e-commerce and risks in brand licensing may erode market share, price power, and operating margins over time.
View narrative
€192.19
FV
29.7% overvalued
intrinsic discount
6.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
14 days ago
author updated this narrative
Spotify Technology
AN
AnalystLowTarget
Consensus Narrative from 37 Analysts
Global Data Privacy Pressures And Licensing Costs Will Constrain Value
Key Takeaways Escalating regulatory scrutiny, rising content costs, and worsening consumer budgets threaten Spotify's margins, advertising revenue, and subscription growth. Heavy bets on podcasts and new content verticals face execution risks, while market saturation and direct artist platforms jeopardize Spotify's long-term earnings stability.
View narrative
US$524.19
FV
27.2% overvalued
intrinsic discount
12.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
14 days ago
author updated this narrative
CNOOC
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Fossil Fuel Demand Will Fall As Renewables And Regulations Intensify
Key Takeaways Rising regulatory, geopolitical, and environmental pressures threaten CNOOC's growth, profitability, and access to key markets and technologies. Heavy focus on offshore oil exploration exposes the company to elevated operational, legal, and transition risks, with limited progress in renewable energy diversification.
View narrative
HK$13.04
FV
43.8% overvalued
intrinsic discount
-4.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
14 days ago
author updated this narrative
Airbus
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Intensifying Climate Policies And Supply Disruptions Will Erode Margins
Key Takeaways Rising regulatory, supply chain, and integration challenges threaten margins, production targets, and financial visibility for Airbus. Emerging market competitors and shifting travel trends risk eroding market share, pricing power, and long-term revenue growth.
View narrative
€141.26
FV
25.9% overvalued
intrinsic discount
9.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
14 days ago
author updated this narrative
Value any company in seconds
Popular companies